Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Eur Thyroid J. 2012 Jul;1(2):99-104. doi: 10.1159/000338920. Epub 2012 Jun 7.
Alcohol consumption has been identified as a protective factor for some autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus.
We hypothesized that alcohol consumption would reduce the risk of developing autoimmune thyroid disease (AITD).
Two nested case-control studies in the prospective Amsterdam AITD cohort. Follow-up was 5 years, with annual assessments. In study A, we compared alcohol consumption between cases (subjects who during follow-up remained euthyroid but developed thyroid peroxidase antibodies (TPO-Ab), called event) and controls (subjects who remained euthyroid and TPO-Ab-negative). In study B, we compared alcohol consumption between cases (subjects who during follow-up developed overt hypothyroidism, called event) and controls (subjects who did not develop overt hypothyroidism). For each case, 2 controls were selected, matched for age, duration of follow-up and smoking behavior at baseline and at the time of event.
In study A, alcohol consumption did not differ between cases and controls at any time point. In study B, the number of subjects consuming >10 units of alcohol per week was not different between cases and controls at study entrance (8.3 vs. 14.5%, NS), but lower at 1 year before (5.3 vs. 19.7%, p = 0.041) and at the time of event (6.7 vs. 23.7%, p = 0.044); respective odds ratios are 0.54 (0.14-2.06), 0.23 (0.05-1.04) and 0.23 (0.05-1.06).
Alcohol consumption is not associated with de novo development of TPO-Ab, but is lower in subjects who developed overt hypothyroidism. The data suggest alcohol consumption may protect against overt autoimmune hypothyroidism.
饮酒已被确定为某些自身免疫性疾病(如类风湿关节炎和系统性红斑狼疮)的保护因素。
我们假设饮酒会降低发生自身免疫性甲状腺疾病(AITD)的风险。
前瞻性阿姆斯特丹 AITD 队列中的两项巢式病例对照研究。随访时间为 5 年,每年进行评估。在研究 A 中,我们比较了病例(在随访期间保持甲状腺功能正常但出现甲状腺过氧化物酶抗体(TPO-Ab)的患者,称为事件)和对照组(在随访期间保持甲状腺功能正常且 TPO-Ab 阴性的患者)之间的饮酒情况。在研究 B 中,我们比较了病例(在随访期间出现明显甲状腺功能减退的患者,称为事件)和对照组(未出现明显甲状腺功能减退的患者)之间的饮酒情况。对于每个病例,选择 2 个匹配年龄、随访时间和基线及事件时吸烟行为的对照。
在研究 A 中,病例和对照组在任何时间点的饮酒量均无差异。在研究 B 中,每周饮酒>10 单位的患者人数在研究开始时(8.3%比 14.5%,NS)和 1 年前(5.3%比 19.7%,p=0.041)以及事件发生时(6.7%比 23.7%,p=0.044)均低于对照组;相应的优势比分别为 0.54(0.14-2.06)、0.23(0.05-1.04)和 0.23(0.05-1.06)。
饮酒与新发生的 TPO-Ab 无关,但在发生明显甲状腺功能减退的患者中饮酒量较低。这些数据表明,饮酒可能对明显的自身免疫性甲状腺功能减退有保护作用。